Award Documents


 

Grant Award Documents

Non-Profit Grant Award Agreement - CARE Distinguished Researchers

For-Profit Grant Award Agreement - CARE Distinguished Researchers (Coming Soon)


 

CARE Policies & Protocols

In order to effectively and professionally meet the goals of the Andy Hill Cancer Research Endowment (CARE) Fund, the following policies and protocols have been adopted by the CARE, effective August 23, 2017. (Updated February 07, 2018)

  1. Conflict of Interest
  2. Confidentiality
  3. Intellectual Property
  4. Spending & Budget Guidelines for Grantees
  5. Grant Matching Funds
  6. Eligibility for Applying for and Receiving a CARE Grant


CONFLICT OF INTEREST:

CARE Authority Directors, Program Administrator (PA), Applicants, Grantees and External Review Contractors

CARE Board Directors and Program Administrator

The policy of the Directors of the Andy Hill Cancer Research Endowment (CARE) is to avoid both actual and apparent conflicts of interest affecting members of CARE’s Board (“directors”) and persons employed and contracted by CARE’s Program Administrator.  In all matters affecting CARE, members of the Board must be guided by the laws relating to CARE and Washington state officers, including but not limited to Chapter 42.52 RCW (Ethics in Public Service), and Chapter 43.348 RCW (CARE enabling statute), and must act in good faith and in the best interests of CARE.  The CARE Program Administrator must act in good faith and in compliance with the terms of State of Washington Services Contract 17-87101-001 without a conflict of interest.

Each director and Program Administrator employee shall disclose to the Board annually, in a form specified by the Board, (i) all affiliations he or she or any immediate family member has with organizations and companies that engaged in or attempted to engage in any transaction with CARE, an applicant organization or grantee during the reporting period; and (ii) any actual or potential conflict of interest that existed or arose during the reporting period.

Upon identification of an actual, potential, or perceived conflict of interest affecting a CARE Board member, committee member or staff person (the “Conflicted Party”), a conflict of interest committee shall be appointed by the Care Board Chair to examine the conflict and recommend a resolution to the full Board.  The full Board will consider the committee’s recommendation and resolve the conflict by taking action to accept, reject or amend the committee’s recommendation.  The Conflicted Party agrees to abide by the Board’s action.

Resolution of conflicts of interest may include but is not necessarily limited to, requiring a Conflicted Party to disclose a conflict and recuse from vote or decision making on the issue/application giving rise to the conflict. To avoid or mitigate the appearance of a conflict a Conflicted Party may publicly acknowledge/disclose the situation that may give rise to the appearance of a conflict and abstain from final Board action on the matter. The Board also may require a Conflicted Party to consult with the Executive Ethics Board and follow its recommendations.

Each CARE director and Program Administrator employee, if any, shall annually sign a statement that affirms such person:

a.    Has received a copy of the conflict of interest policy;
b.    Has read and understands the policy; and,
c.     Has agreed to comply with the policy.

CARE Applicants and Grantees

In making an application to CARE for grant funding and executing a CARE grant agreement, if any, an organization acknowledges and agrees that it is in compliance with any applicable requirements regarding Conflict of Interest, including but not necessarily limited to any financial conflict of interest,  as required by the U.S. Department of Health and Human Services (DHHS)/Public Health Services (PHS), if applicable.

External Review Contractors

Any CARE external reviewers and contractors are required to remain in compliance with the conflict of interest terms of their respective agreements with CARE.


CONFIDENTIALITY:

CARE Authority Directors, Program Administrator (PA), Applicants, Grantees, and External Review Contractors

Information in grant applications is received by CARE with the understanding that it shall be used or disclosed solely for evaluation of applications or as required by law. CARE holds all applications confidential in accordance with its confidentiality procedures and subject to the public disclosure laws of the State of Washington. (For more information about Washington public disclosure law, applicants are referred to Chapter 42.56 RCW and to the amendments to the exemption provisions in RCW 42.56.270.)

If the applicant believes the above provisions or any other provisions in the Public Records Act is applicable to its proposal in response to the CARE RFP, the applicant must mark all relevant information as confidential. The applicant will be notified of any public disclosure request with regard to its proposal and be afforded an opportunity to provide further information specifying why the information is exempted from disclosure under the above provision or any other application exemption from disclosure, and the opportunity to assert objections to disclosure and seek a protective order. CARE will determine, in its sole discretion, whether to assert any available public records exemption.

In the case of the submission of an LOI and/or proposal, CARE may make public the name of the applicant, the applicant organization, the title of the project, the dates of the proposed grant period, the funding amount requested, and contact and demographic data. For unfunded applications, CARE will not release the abstract or narrative of the proposed work, the budget, or any identifiers regarding co-applicant organizations, to the extent disclosure of these items might be reasonably expected to result in private loss to the applicant organizations, and as is consistent with applicable exemptions to disclosure. If a proposal is funded, CARE may make public certain additional information from the application, including an abstract of the work and the names and contact information of any co-investigators or co-applicant organizations.

In response to a public disclosure request for a funded application under Washington State law, CARE may provide further information to the requester, but only to the extent that provision of such information would reasonably not be expected to result in private loss to the providers of such information. If CARE receives a public records request for a funded or unfunded application, it will notify the applicant organization of such a request in a timely manner in order to allow the organization the opportunity to assert objections to disclosure in any applicable proceeding.

CARE reserves the right to publicly disseminate information about a grantee’s activities in public reports, on its website, in press releases, speaking engagements, and other public venues. CARE shall not publicly disclose information that has been marked as proprietary or confidential if such information has not been previously disclosed to the public, or other information to the extent that provision of such information would reasonably be expected to result in private loss to the providers of such information.

[Note: RCW 42.56.270 was amended to include an exemption for CARE grant applications from public disclosure for “[f]inancial, commercial, operations, and technical and research information and data submitted to or obtained by the Andy Hill cancer research endowment program in applications for, or delivery of, grants under chapter 43.348 RCW, to the extent that such information, if revealed, would reasonably be expected to result in private loss to providers of this information.” However, while CARE will treat progress reports in the same manner as applications as described above, the public records exemption allowed under RCW 42.56.270(29) may not extend to progress and final reports. CARE will make reasonable efforts to protect information, that if disclosed, may lead to private loss to the providers of such information. Additionally, if CARE receives a public records request for a grantee’s progress report, it will notify the grantee of such a request in a timely manner in order to allow the organization the opportunity to assert objections to disclosure in any applicable proceeding.]


INTELLECTUAL PROPERTY

CARE does not expect to assert intellectual property rights related to inventions, discoveries, and/or copyrights that result from the work of an investigator recruited under the CARE Distinguished Researcher program or the research carried out under the CARE Breakthrough Research Program.

CARE, however, does expect such inventions, discoveries, and/or copyrights to be reported to CARE. Grantees must report all inventions developed through CARE grant-funded activities or research projects to CARE. CARE does not intend to assert ownership of any invention that is derived from CARE funded research. However, if the grantee organization, or any subcontractor, decides not to take title and file an application for intellectual property protection, CARE would then have the option to take title. The grantee must notify CARE prior to any publication of the invention so as to allow CARE to take title and pursue or maintain intellectual property protection.

CARE does not expect to require payback of grants awarded based on income generated from sale or commercialization of any inventions resulting from CARE grant-funded activities or research. This approach is intended to minimize intellectual property-related barriers for potential applicants and encourage pursuit of transformational research. Successful projects will stimulate economic development through job creation and infusion of additional research funds to Washington. Products derived from these inventions will then be available to the public, with the expectation that it will improve health outcomes for the people of Washington and globally.

CARE must be listed as a funder in all presentations, publications, and patent applications.


SPENDING & BUDGET

Guidelines for Grantees

CARE provides the following information to assist individuals and organizations who are interested in applying for CARE funds. These guidelines are subject to change and are not intended to be all-inclusive.

CARE’s allowable costs are based on the following assumptions:

  1. Costs are reasonable and necessary to recruit the Distinguished Researcher or to carry out the research;
  2. Costs are allocable to the specific grant;
  3. Costs conform to the specific CARE approved grant proposal/award;
  4. The relative spend down rate of CARE and non-CARE funds is 1:1; AND
  5. Allowable non-state match funds have been secured and satisfactorily demonstrated to CARE.

Distinguished Researcher Program

Grant funding provided through the CARE Distinguished Researcher Program is intended to leverage and augment other non-state funding to successfully attract and retain best-in-class researchers, and to accelerate the accomplishment of their research vision or plan. CARE encourages grantees to utilize CARE funding in such a way that recruitment, retention, and additional leveraged research funding is maximized. As such, the following set of principles have been established to accomplish those efforts.

  1. Direct costs for PI salary, laboratory staff, supplies, non-capital instruments, equipment, materials and animal-related tied to the research plan are all allowable. Other costs associated with unique recruitment efforts to attract talent to Washington State will be considered. Costs will be evaluated based on clear demonstration that such expenditures are in fact additive, leveraged and necessary to enable successful recruitment.
  2. Grant expenditures may be spread over a period of up to 5 years. Annual reporting on key high-level metrics such as research accomplishments, additional leveraged research funding, and job creation will be requested for each year of active grant funding, as well as 2 years post grant close-out. (These reporting requirements are not intended to be burdensome to the grantee, but rather high-level, and illustrative of the important leveraging effect achieved by public investment in important cancer research efforts.)
  3. CARE Funds are intended to advance cancer research efforts, and therefore may not be used to pay for expenses related to PI community service, teaching, or clinical activities.

Breakthrough Research Program

Grant funding provided through the CARE Breakthrough Research Program is intended to leverage and augment non-state sources to support innovative research and collaborations that have the potential for the next breakthrough discovery in cancer research. Specific allowable costs are outlined in the CARE Policies and Protocols document. Additional allowable costs and restrictions may be found in the current program description.


MATCHING FUNDS

Guidelines for Applicants and Grantees

CARE provides the following information to assist individuals and organizations who are interested in applying for CARE funds. These guidelines are subject to change and are not intended to be all-inclusive.

CARE’s allowable match funds are based on the following assumptions:

  1. The financial source of the match was not from Washington State appropriations;
  2. There is documentation of the cost calculation and a binding enforceable agreement stipulating use of the resource for the proposed research/researcher; AND
  3. The costs are/were used as outlined in the approved grant application proposal

Examples of match type and allowableness are outlined in the CARE Policies and Protocols document.

Distinguished Researcher Program

Recruiting organization must demonstrate proof of non-state matching financial support of a minimum of 1:1 (e.g., if requesting $300,000, applicant must demonstrate proof of not less than $300,000 in non-state match). Each grant awarded through the CARE Distinguished Researcher program is limited to a maximum of $500,000 total.

Breakthrough Research Program

Breakthrough Research organizations must also demonstrate proof of non-state matching financial support of a minimum 1:1. A minimum of 1:1 non-state match for first-year research planning must be secured at the time of the application submission. Organizations must also demonstrate 1:1 non-state match for all continued funding (years 2–5), or a strong fund development plan for raising the back-end match after the initial research planning and feasibility studies period. If a fund development plan is proposed, the applicant organization must guarantee 100% of the match in a written, binding, enforceable agreement upfront. All match funds must be committed before the end of the full grant period. In other words, the applicant must be committed to backstopping all match dollars that are not successfully raised in the proposed back-end fund development plan through other means.  

Proof of non-state or private matching contributions may be accomplished by either:

  • Evidence of deposit into the Andy Hill CARE Fund; OR
  • A written, binding, enforceable agreement from the contributor that commits an equal or greater amount of non-state or private contributions to the Andy Hill CARE Fund, and that acknowledges that the state match CARE funds are contingent upon this contribution.

Funds from Federal sources are considered “non-state” funds, and therefore are eligible to count as matching funds, as long as the above proof can be provided.

All funding from the CARE Fund is contingent upon availability of funds appropriated by the Washington State legislature and secured by other sources.


ELIGIBILITY

Applying for and Receiving a CARE Grant

As stated in RCW 43.348.040 (1), the purpose of the CARE “program is to make grants to public and private entities, including commercial entities, to fund or reimburse the entities pursuant to agreement for the promotion of cancer research to be conducted in the state.” Therefore, institutions of higher education, non-profit, and commercial entities are eligible to apply for CARE grants. Grant-related activity must occur in its entirety within the State of Washington, unless otherwise included in the project’s statement of work and approved in advance by the Program Administrator.

For the Breakthrough Research Program, collaborations or partnerships with institutions and researchers outside of Washington State are permitted. However, no more than 20% of CARE funds and 20% of matching funds may be allocated to out-of-state partners or researchers. Additionally, grantees must make best efforts to purchase goods and services from Washington suppliers to the extent reasonably possible, where such goods and services are available, and are comparable in quality and utility, and the price is not more than 20% higher than that of the non-Washington State supplier.

Applicant organizations may submit multiple applications for the same funding round.

Receiving a CARE grant is conditional on the applicant executing a CARE Grant Award Agreement.